Inspiring Progress

30
Sep

Rising Tide Newsletter Q3 2022

By Brent MacDonald

  *|MC_PREVIEW_TEXT|*     Dear Esteemed Partners and Friends: Welcome to our Quarterly Newsletter that recaps how Rising Tide connects capital with the opportunity to create value and build a better future. Our business is and will always be susceptible to market conditions, so we take great pride in our portfolio’s performance and consistent growth, […]

02
Sep

By Brent MacDonald – Principal @ Rising Tide VC Synthetic biology has the potential to solve some of the world’s most intractable problems, but we require innovation in gene synthesis to accelerate progress At Evonetix they are reimagining biology by developing a radically different approach to gene synthesis – a highly parallel desktop platform to synthesize DNA at an […]

01
Sep

ByBrent MacDonald – Principal at Rising Tide Twelve, formerly Opus 12, headquartered in Berkeley, California, has developed a device that recycles carbon dioxide (CO2) into cost-competitive chemicals and fuels. The Company’s technology bolts onto any source of CO2 emissions, and with only water and electricity as inputs, transforms that CO2 into some of the world’s most critical chemical and […]

01
Sep

By Brent MacDonald – Principal @ Rising Tide VC A surgeon’s decision-making abilities during a procedure are indubitably seconded by none. However, certain steps in any surgery–even in standard surgical procedures–require surgeons to make decisions based on not only what they can see, but what they cannot see as well. Regularly, surgeons are forced to make vital […]

01
Sep

By Brent MacDonald – Principal @ Rising Tide   Tribal Raises $60M in Oversubscribed Series B Tribal Raises $40M in Crypto-TradFi Debt Round to Power Payments, Financing for LatAm SMBs The startup economy is booming in emerging markets, but the banking infrastructure that should support it is broken. A huge gap exists between the financial services offered […]

01
Sep

By Brent MacDonald – Principal @ Rising Tide VC Molecular Assemblies is a life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The Company’s patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high-quality, sequence-specific DNA reliably, affordably, and sustainably. Scientists at Molecular […]